Gabapentin
Product Images NDC 68788-8687

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-8687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Tablets 800mg Cv (156fe804 D674 4b52 82f5 6cd7715c707b 00)

Label for Gabapentin Tablets 800mg, a generic for Neurontin, manufactured by ACI HealthCare Limited and labeled by Preferred Pharmaceuticals Inc. The label includes storage instructions, barcode, dosage directions in English and Spanish, and caution about drug transfer. Specific package size, lot number, batch number, and expiration date fields are present but not filled in.*

FDA Label Image

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

An illustration showing the formula to calculate creatinine clearance (CLCr) based on age in years, weight in kilograms, serum creatinine in mg/dL, and a gender adjustment factor of 0.85 for female patients.*

FDA Label Image

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

Chemical structure of Gabapentin showing a cyclohexane ring bonded to a carbon with amine (CH2NH2) and carboxyl (CH2CO2H) functional groups.*

FDA Label Image

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

A line graph displaying mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration and a 4-week fixed dose period; the y-axis shows mean pain score values from 0 to 10. Gabapentin shows a notable decrease in mean pain score compared to placebo.*

FDA Label Image

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

A line graph comparing the mean pain score over 7 weeks for three groups: placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, showing decreasing pain scores over time for the Gabapentin groups compared to placebo.*

FDA Label Image

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) treatment groups across two studies. The y-axis shows percentage responders from 0% to 100%. Study 1 shows 12% response for placebo and 29% for Gabapentin 3600 mg. Study 2 shows 14% response for placebo, 32% for Gabapentin 1800 mg, and 34% for Gabapentin 2400 mg. Statistical significance indicators are noted for Gabapentin groups.*

FDA Label Image

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

A scatter plot chart showing differences in percentage on the y-axis and daily dose in milligrams on the x-axis for Gabapentin. Data points represent three studies labeled Study a, Study b, and Study c, showing variation in difference values across doses of approximately 600 mg, 900 mg, 1200 mg, and 1800 mg.*

FDA Label Image

Gabapentin Tab 600mg Cv (Label 600 100 Ahl)

Gabapentin Tab 600mg (CV) packaging label from Preferred Pharmaceuticals, Inc. The label indicates the product is generic for Neurontin, with each tablet containing 600mg of Gabapentin. It includes storage instructions, manufacturer information (ACI HealthCare Limited), and cautions about federal law restricting transfer of the drug. The label also has sections for directions in English and Spanish.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.